LifeMD to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021 NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, has been invited to participate at the 33rd Annual ROTH Growth Conference...

Conversion Labs Appoints Digital Marketing Executive, Bryant Hussey, as Chief Digital Officer NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed digital marketing expert and industry thought-leader,...

Conversion Labs Appoints Expert Life Sciences Attorney, Eric H. Yecies, as Chief Compliance Officer and General Counsel NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed expert Life Sciences attorney, Eric H....

Conversion Labs Reports May 2020 Net Revenues up 274% to Record $3.2 Million, on Track to Exceed 3x Growth in 2020 NEW YORK, June 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported record net revenues of $3.2 million for the month...

Conversion Labs Appoints Award-Winning Physician, Dr. Jeremy Fine, to Advisory Board to Advance Telemedicine Brand Portfolio NEW YORK, April 14, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed Dr. Jeremy Fine, a noted expert in internal...